Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Drug Discovery Today|March 15, 2006
Role of pharmacologically active metabolites in drug discovery and developmentAberra FuraJournal of Clinical Pharmacology|February 11, 2025
Navigating First-in-Human and Early-Phase Patient Studies: Study Designs, Risk Mitigation, and Population Selection ChallengesJocelyn Courville, Amanda Barber, Aberra FuraBiopharmaceutics & Drug Disposition|November 8, 2008
Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compoundsAberra Fura, Viral Vyas, William Humphreys, et al.Journal of Pharmaceutical and Biomedical Analysis|October 21, 2003
Shift in pH of biological fluids during storage and processing: effect on bioanalysisAberra Fura, Timothy W Harper, Hongjian Zhang, et al.Clinical Pharmacokinetics|January 22, 2018
Daclatasvir: A Review of Preclinical and Clinical PharmacokineticsYash Gandhi, Timothy Eley, Aberra Fura, et al.Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetesRobert P Brigance, Wei Meng, Aberra Fura, et al.The Lancet. Rheumatology|January 22, 2024
Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design studyPhilip G Conaghan, Miroslawa Nowak, Shuyan Du, et al.Endocrinology|January 8, 2005
A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivoBrian J Arey, Ramakrishna Seethala, Zhengping Ma, et al.Analytical and Bioanalytical Chemistry|December 2, 2011
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodiesShujie J Wang, Steven T Wu, Jochem Gokemeijer, et al.Clinical Pharmacology in Drug Development|October 22, 2020
Population Pharmacokinetic Analysis of BMS-986166, a Novel Selective Sphingosine-1-Phosphate-1 Receptor Modulator, and Exposure-Response Assessment of Lymphocyte Counts and Heart Rate in Healthy ParticipantsSébastien Bihorel, Shalabh Singhal, Diane Shevell, et al.Pageof 5